Genetics and anorexia nervosa: A review of candidate genes

Psychiatric Genetics

Volumn 8, Issue 1, 1998, Pages 1-12

  Gorwood, P ^a,b   Bouvard, M ^c   Mouren Simeoni M C ^c   Kipman, A ^a,c   Ades J ^a  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSERM   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Anorexia nervosa; Candidate genes; Genetics

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; NORADRENALIN; OPIATE; OPIATE RECEPTOR; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA NERVOSA; DIZYGOTIC TWINS; DOPAMINERGIC SYSTEM; GENETIC RISK; HEREDITY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MONOZYGOTIC TWINS; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0031896285     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199800810-00001     Document Type: Review

References (162)

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, et al. (1996). A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945-1949.
2. Advokat C, Kutlesic V (1995). Pharmacotherapy of the eating disorders: a commentary. Neurosci Biobehav Rev 19:59-66.
3. Baik JH, Picetti R, Salardi A, Thiriet G, Dierich A, Depaulis et al. (1995). Parkinson-like locomotor impairment in mice lacking dopamine receptors. Nature 377:424-428.
4. Ball D, Curtis D, Collier D (1995). A highly polymorphic dinucleotide repeat marker in the brain CCK receptor gene CCK-B. Psy Gen S5-96.
5. Barbeau AM, Mars H, Gillo-Joffroy L (1971). Adverse clinical side effects of levodopa therapy. In: Recent Advances in Parkinson's disease (Eds FH McDowell, A. Barbeau). Philadelphia; FA Davis.
6. Bartoshuk L, Duffy V, Reed D, Williams A (1996). Supertasting, earaches and head injury: genetics and pathology alter our taste worlds. Neurosci Biobehav Rev 20:79-87.
7. Barry VC, Klawans HL (1976). On the role of dopamine in the pathophysiology of anorexia nervosa. J Neural Transm 38:107-122.
8. Barzaghi F, Gropetti A, Mantegazza P (1973). Reduction of food intake by apomorphine: a pimozide-sensitive effect. J Pharm Pharmac 25:909-911.
9. Beaumont P, Abraham S, Argall W, George G, Gluan P (1978). The onset of anorexia nervosa. Australian and New Zealand J of Psychiatr 12:145-149.
10. Blackburn J, Phillips A, Jakubovic A (1989). Dopamine and preparatory behaviour: II. A neurochemical analysis. Behav Neurosci 103:15-23.
11. Blessing W, Sved A, Reis D (1982). Destruction of noradrenergic neurons in rabbit brainstem elevates plasma vasopressin, causing hypertension. Science 217:661-663.
12. Blundell J, Hill A (1991). Serotonin, eating disorders and the satiety cascade. In: Eds CB Cassano & HS Akiskal. Serotonin Related Psychiatric Syndromes: Clinical and Therapeutic Links. Royal Society of Medicine, Services International Congress and Symposium, Series No. 165, pp. 125-129. London, Royal Society of Medicine, Services International Congress and Symposium, Series No. 165, pp. 125-129. London, Royal Society of Medicine.
13. Booth D (1973). Amphetamine anorexia by direct action on the adrenergic feeding system of rat hypothalamus. Nature 217:869-870.
14. Bouchard C, Tremblay A, Despres J, Poehlman E, Theriault G, Nadeau A et al. (1988). Sensitivity to overfeeding: the Quebec experiment with identical twins. Prog Food Nutr Sci 12(1):45-72.
15. Bouten C, van Marken Lichtenbelt W and Westerterp K (1996). Body mass index and daily physical activity in anorexia nervosa. Med Sci Sports Exerc 28:967-73.
16. Brewerton T, Brandt H, Lessem M, Murphy D, Jimerson D (1990). Serotonin in eating disorders. In: (Eds DL Murphy and EF Coccaro). Serotonin in Major Psychiatric Disorders, pp. 153-184. Washington DC, American Psychiatric Press.
17. Bruch H (1973). Eating disorders: obesity, anorexia nervosa and the person within. Basic Books, New York.
18. Bruins-Slot L. Gorwood P, Bouvard M, Blot P, Adès J, Feingold J et al. Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biol Psychiatry 43:76-78.
19. Buvat-Herbaut M, Hebbinchuys P, Lemaire A, Buvat J (1983). Attitudes towards weight, body image, eating, menstruation, pregnancy and sexuality in 81 cases of anorexia nervosa compared to 281 normal control school girls. Int J of Eat Disord 2:45-59.
20. Cantwell DP, Sturzenberger S, Burroughs J, Salkin B, Green JK (1977). Anorexia nervosa: an affective disorder? Arch of Gen Psychiatry 34:1087-1093.
21. Carlisle HJ (1964). Differential effects of amphetamine on food and water intake in rats with lateral hypothalamic lesions. J Comp Physiol Psychol 58:47-54.
22. Carter A, Davis ST (1977). Biogenic amines, reproductive hormones and female sexual behaviour: a review. Behav Res 1:213-225.
23. Casper R (1996). Carbohydrate metabolism and its regulatory hormones in anorexia nervosa. Psychiatry Res 16-62(1):85-96.
24. Cloninger CR (1987). Neurogenetic adaptive mechanisms in alcoholism, Science 236:410-416.
25. Collier D, Arranz M, Li T, Mupita D, Brown N, Treasure J (1997). Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet 350:412.
26. Comuzzie A, Hixson J. Almasy L, Mitchell B, Mahaney M, Dyer T et al. (1997). A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 15:273-276.
27. Considine R, Sinha M, Heiman M, Kriauciunas A, Stephens T, Nyce M et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295.
28. Coughlin SS, Benichou J, Weed DL (1994). Attributable risk estimation in case control studies. Epidemiological Reviews 16:51-64.
29. Crisp AH, Hsu LFG, Harding B, Hartshorn J (1980). Clinical features of anorexia nervosa. A study of consecutive series of 102 female patients. J Psychosom Res 24:179-191.
30. Curzon G (1991). Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding. Adv Exp Med Biol 294:377-388.
31. Dally P, Gomez J (1979). Anorexia Nervosa. William Heinemann, London.
32. Donohoe T (1984). Stress-induced anorexia: implications for anorexia nervosa. Life Sciences 34:203-218.
33. 1A dopamine receptors. Proc Natl Acad Sci USA 91:12546-12568.
34. Drago J, Gerfen C, Westphal H, Steiner H (1996). D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74:813-823.
35. Eckert E, Goldberg S, Halmi K, Caspar R, Davis J (1979). Alcoholism in anorexia nervosa. In: Eds RW Pickens and LL Heston. Gruyne and Stratton, New York. Psychiatric Factors in Drug Abuse.
36. Ellinwood E (1969). Amphetamine psychosis: a multiple-dimensional process. Semin Psychiatry 1:208-226.
37. Ellinwood E, Sudilovsky A, Nelson L (1973). Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry 130:1088-1093.
38. Falconer D (1965). The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet 29:51-76.
39. Garfinkel P, Garner D (1982). Anorexia Nervosa a Multidimensional Perspective. Brunner/Mazel, New York.
40. Garfinkel P, Moldofsky H, Garner D (1980). Heterogeneity of anorexia nervosa: bulimia as a distinct syndrome. Arch Gen Psychiatry 37:1036-1040.
41. Geracioti T, Liddle R, Altemus M, Demitrack M, Gold P (1992). Regulation of appetite and cholecystokinin secretion in anorexia nervosa. Am J Psychiatry 149:958-961.
42. Gerner R, Sharp B (1982). CSF-β-endorphin-immunoreactivity in normal, schizophrenic, depressed, manic and anorexic subjects. Brain Res 237:244-247.
43. Gerner R, Cohen D and Fairbanks L (1984). CSF neurochemistry of women with anorexia nervosa and normal women. Am J Psychiatry 141:1441-1444.
44. Gershon E, Hamovit J, Schreiber J, Dibble E, Kaye W, Nurneberger J, Andersen A, Ebert M (1983). Anorexia nervosa and major affective disorders associated in families: a preliminary report. In: Childhood Psychopathology and Development (Eds. SB Guze, FJ Earls, JE Barrett), Raven Press, New York.
45. Gershon E, Hamovit J, Schreiber J, Hamovit J, Dibble E, Kaye W, Nurnberger J, Andersen A, Ebert M (1984). Clinical findings in patients with anorexia nervosa and affective illness in their relatives. Am J Psychiat 141:1419-1422.
46. Giros B, Jaber M, Jones S, Wightman RW, Caron M (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
47. Goodall E, Trenchard E, Silverstone T (1987). Receptor blocking drugs and amphetamine anorexia in human subjects. Psychopharmacol 92:484-490.
48. Goodall E, Silverstone T (1988). Differential effect of d-fenfluramine and metergoline on food intake in human subjects. Appetite 11:215-228.
49. Goodall E, Feeney S, McGuirk J, Silverstone T (1992). A comparison of the effects of d and 1 enfluramine and d-amphetamine on energy and macronutrient intake in human subjects. Psychopharmacol 106:221-227.
50. Gosnell BA (1987). Central structures involved in opioid-induced feeding. Fed Proc 46:163-167.
51. Grandy DK, Zhou QZ, Allen L, Litt R, Magenis R, Civelli O, Litt M (1990). A human D1 dopamine receptor gene is located in chromosome 5 at q35.1 and identifies an EcoRI RFLP. Am J Hum Genet 47:828-834.
52. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E et al. (1996). Serum leptin levels in women with anorexia nervosa. J Clin Endocrinal Metab 81:3861-3863.
53. Haleem DJ (1988). Serotoinergic functions in rat brain: sex related differences and responses to stress. PhD Thesis, University of London.
54. Halmi KA, Goldberg SC, Eckert E, Casper R, Davis J (1997), Pretreatment evaluation in anorexia nervosa. In: Anorexia Nervosa. (Ed. RA Vigersky). Raven, New York.
55. Harty R, Pearson P, Solomon T, McGuigan J (1993). Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul Pept 36:141-150.
56. Hauge XY, Grandy DK, Eubanks JH, Evans G, Civelli O, Litt M (1991). Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics 10:527-530.
57. Heils A, Teufel A, Petri S, Ströber G, Riederer P, Bengel D, Lesch K (1996). Allelic variation of human serotonin transporter gejie expression. J Neurochem 66:2621-2624.
58. Herpertz-Dahlmann (1988). Familiäre belastungen mit affekitven Erkrankungen von Patienten mit Anorexia Nervosa. Z Kinder-Jugendpsychiat 16:14-19.
59. Hoek HW (1993). Review of the epidemiological studies of eating disorders. Intl Rev of Psychiatry 5:61-74.
60. Holland AJ, Hall A, Murray R et al. (1984). Anorexia nervosa: a study of 34 pairs of twins and one set of triplets. Brit J Psychiatry 145:414-419.
61. Holland A, Sicotte N, Treasure J (1988). Anorexia nervosa: evidence for a genetic basis. J of Psychosomatic Res 32:561-571.
62. Holland A, Treasure J, Coskeran P, Dallow J (1995). Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment. J Intellect Disabil Res 39:373-381.
63. 2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids. J Neurosci 17:4056-4065.
64. Hudson J, Pope H, Jonas J, Yorgelun-Todd D (1983). A family study of anorexia nervosa and bulimia. Brit J Psychiatry 142:133-138.
65. Huidobro-Toro J, Way L (1985). Opiates. Psychopharmacol 2:283-318.
66. Iversen L (1967). The uptake and storage of noradrenaline in sympathetic nerves. University Press, Cambridge.
67. Jacquart A (1983). Heritability; one word, three concepts. Biometrics 39:465-477.
68. Janet P (1907). The Major Symptoms of Hysteria. Macmillan, London.
69. Jensen L (1968). Anorexia nervosa. Acta Psychiatrica Scand 203:113-116.
70. Joseph R (1996). The Neuropsychology of Repression. In: Neuropsychiatry, Neuropsychology, and Clinical Neuroscience. (Ed. Phacon Joseph). Williams and Wilkins. pp. 521-563. Baltimore, USA.
71. Kalant H (1985). Tolerance, learning and neurochemical adaptation. Can J Physiol Pharmacol 63:1485-1494.
72. Katz J (1975). Psychoendocrine considerations in anorexia nervosa. Topics in Psychoendocrinology (Ed. E. Sacher). Grune & Stratton, pp. 121-133. New York.
73. Kaye WH, Pickar D, Nabar D, Ebert MH (1982). Cerebrospinal fluid opioid activity in anorexia nervosa. Am J Psychiatry 139:643-645.
74. Kaye WH, Berrettini WH, Gwirtsman HE, Chretien M, Gold PW, George DT et al. (1987). Reduced cerebrospinal fluid levels of immunoreactive proopiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa. Life Sciences 41:2147-2155.
75. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH (1988). CSF 5-H1AA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 23:102-105.
76. Kelsoe J, Stubblefield B and Ginns E (1988). Human tyrosine hydroxylase (TH) genomic fragment (pHGTH4) identifies a PstI polymorphism. Nucl Acids Res 16:7760.
77. Khanna JM, Kalant H, Lê AD, LeBlank AE (1980). Role of serotonin (5-HT) in drug tolerance and general adaption. Acta Psychiatrica Scandinavia 286:Suppl, 161.
78. Kimura T, Share L, Wang B, Crofton J (1981). The role of central adrenoreceptors in the control of vasopressin release and blood pressure. Endocrinology 108:1829-1836.
79. Kissif H, Pi-Sunyer F, Thorton J, Smith G (1982). C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutrition 34:154-160.
80. Krahn DD, DeQuardo J, Gosnell BA (1990). Opiate addiction and anorexia nervosa: a case report. Int J Eat Disord 9:453-456.
81. Krulich LA, Giachetti A, Marchlewdkako JA, Hefco E, Jameson H (1977). On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology 100:496-505.
82. 2C receptor gene (HTR2C). Genomics 27:274-279.
83. 1Db autoreceptor genes on chromosome 6 and direct analysis for sequence variants. Am J of Med Genetics (Neuropsychiatric Genetics) 60:157-161.
84. Leibowitz SF (1986). Brain monoamines and peptides: role in the control of eating behaviour. Fed Proc 45:1396-1403.
85. Leibowitz SF (1970). Reciprocal hunger-related circuits involving alpha and beta adrenergic receptors located, respectively, in the ventromedial and lateral hypothalamus. Proc Nat Acad Sci 67:1063-1070.
86. Levy AB, Dixon KN (1985). The relationship between anorexia nervosa and depression: a reevaluation. Int J of Eating Disorders 4:389-405.
87. Li T, Sham P, Vallada H, Xie T, Tang X, Murray R et al. (1996). Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet 6:131-133.
88. Licinio Paixao J (1989). Hyperinsulinemia; a mediator of decreased food intake and weight loss in anorexia nervosa and major depression. Med-Hypotheses 28:125-130.
89. Lippa AS, Antelman SM, Fisher AE, Canfield RD (1973). Neurochemical mediation of reward: a significant role of dopamine? Pharmacol Biochem Behav 1:23-28.
90. Logue CM, Crowe RR, Bean JA (1989). A family study of anorexia nervosa and bulimia. Compr Psychiatry 30:179-188.
91. Luby ED, Marrazzi M (1987). Treatment of eating disorders with narcotic antagonists. Society for Neuroscience [Abstract] 13:879.
92. Lytle LD (1970). The ontogeny of lateral hypothalamic control of feeding and drinking in the rat. Unpublished dissertation, Princeton University.
93. McGuffin P, Katz R (1986). Nature, nurture and affective disorder. In: The Biology of Depression (Ed. JFW Deakin). Gaskell Press, London.
94. Maloney M, Shephard-Spiro P (1983). Eating attitudes and behaviours of anorexia nervosa patients and their sisters. Gen Hospital Psychiatry 5:285-288.
95. Mauriege P, Bouchard C (1996). Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 348:698-699.
96. Melchior CL, Tabakoff B (1981). Modification of environmentally cued tolerance to ethanol in mice. J Pharmacol Exp Ther 219:175-180.
97. Mollereau C, Parmentier M, Mailleux P, Butour J, Moisand C, Chalon P et al. (1994). ORL 1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341:33-38.
98. Morgan HG, Russel GFM (1975). Value of family background and clinical features as predictors of long term outcome in anorexia nervosa. Four years follow-up study of 41 patients. Psychol Med 5:355.
99. Namias J, Burly M, Povey S, Porter C, Craig L, Wolfe J (1992). A 19bp deletion polymorphism adjacent to a dinucleotide repeat polylymorphism at the human dopamine-β-hydroxylase locus. Human Molecular Genetics 1:286.
100. Obarzanek E, Lesem M, Jimerson D (1994). Resting metabolic rate of anorexia nervosa patients during weight gain. Am J Clin Nutr 60(5):666-675.
101. Overstreet D, Rezvani A, Knapp D, Crews F, Janowsky D (1996). Further selection of rat lines differing in 5-HT-1A receptor sensitivity: behavioural and functional correlates. Psychiatr Genet 6:107-117.
102. Ozaki N, Lappalainen J, Dean M, Virkunnen M, Linnoila M, Goldman D (1995). Mapping of the serotonine 5-HT1Da autoreceptor gene (HTR1D) on chromosome 1 using a silent polymorphism in the coding region. Am J Med Genetics (Neuropsychiatric Genetics) 60:162-164.
103. Pahl J, Pirke KM, Schweiger U, Warnholl M, Gerlinghoff M, Brinkman W et al. (1985). Biol Psych 20:874-887.
104. Pasternak G, Pan Y, Cheng J (1995). Correlating the pharmacology and molecular biology of opioid receptors. Cloning and antisense mapping a kappa 3-related opiate receptor. Ann NY Acad Sci 757:332-338.
105. Pfaus JG, Damsma G, Nomikos GG, Winkstern D, Blaha C, Phillips A, Fibiger H (1990). Sexual behaviour enhances central dopamine transmission in the male rat. Brain Res 530:345-348.
106. Phillipp E, Pirke K, Kellner M, Krieg J (1991). Disturbed cholecytoskinin secretion in patients with eating disorders. Life Sci 48:2443-2450.
107. Platte P, Pirke K, Trimborn P, Pietsch K, Krieg J, Fichter M (1994). Resting metabolic rate and total energy expenditure in acute and weight recovered patients with anorexia nervosa and in healthy young women. Int J Eat Disord 16:45-52.
108. Ramboz S, Saudou F, Amara DA, Belzung C, Segu L, Misslin R et al. (1996). 5-HT1B receptor knock out -behavioural consequences. Behav Brain Res 73:305-312.
109. Rastam M, Gillberg C, Garton M (1989). Anorexia nervosa in a Swedish urban region. A population-based study. Br J of Psych 155:642-646.
110. Reich T, James JW, Morris CA (1972). The use of multiple thresholds in determining the mode of transmission of semi-continuous trials. Ann Hum Genet 36:163-183.
111. Rieg T, Aravich P (1994). Systemic clonidine increases feeding and wheel running but does not affect rate of weight loss in rats subjected to activity-based anorexia. Pharmacol Biochem Behav 47:215-218.
112. n-dinucleotide repeat polymorphism at the locus for the alpha2C adrenergic receptor (ADRA2C) on 4q16. Human Molecular Genetics 1:452.
113. Risinger F, Bormann N, Oakes R (1996). Reduced sensitivity to ethanol reward, but not ethanol aversion, in mice lacking 5-HT1B receptors. Alcohol Clin Exp Res 20:1401-1405.
114. Rivinus TM, Biederman J, Herzog DB, Kemper K, Harper GP, Harmatz JS, Houseworth S (1984). Anorexia nervosa and affective disorders: a controlled family history study. Am J Psychiatry 141:1414-1418.
115. Rotondo A, Schuebel KE, Nielsen DA, Michelli S, Lezza A, Coli E et al. (1997). Tryptophan hydroxylase promoter polymorphisms and anorexia nervosa. Biol Psychiatry 42:995.
116. Rowland NE (1986). Effect of continuous infusion of dexfenfluramine on food intake, body weight and brain amines in rats. Life Sciences 39:2581-2586.
117. Rubinsztein D, Leggo J, Goodburn S, Walsh C, Jain S, Paykel E (1996). Genetic association between monoamine oxidase. A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum Mol Genet 5:779-782.
118. Russel G, Bearwood C (1970). Amenorrhea in the feeding disorders: anorexia nervosa and obesity. Psychother Psychosom 18:359.
119. Rutherford J, McGuffin P, Katz RJ, Murray RM (1993). Genetic influences on eating attitudes in a normal female twin population. Psychol Med 23:425-436.
120. Sawyer CH, Hilliard J, Kanematsu S, Scaramuzzi R, Blake C (1974). Effects of intraventricular infusions of norepinephrine and dopamine on LH release and ovulation in the rabbit. Neuroendocrinology 15:328-337.
121. Schmidt U, Tiller J, Treasure J (1983). Psychosocial factors in the origins of bulimia nervosa. International Review of Psychiatry 5:51-60.
122. Schepank HGF (1981). Anorexia nervosa: Zwillings kasuistik über ein seltenes Krankheitsbild. In: Ursprunge Seelisch Bedingter Krankheiten, Vol. 2 (Eds A. Heigl-Evers, H. Shepank). Verlag für Medizinische Psychologie in Verlag Vandenhoeck und Ruprecht Gottingen, West Germany.
123. Scott D (1986). Anorexia nervosa: a review of possible genetic factors. Int J Eat Disord 5:1-20.
124. Silverstone T, Stunkard AJ (1968). The anorectic effect of dexamphetamine sulphate. Br J Pharmacol Chemoth 33:513-522.
125. Simon Y, Bellisle F, Monneuse M, Samuel-Lajeunesse B, Drewnowski A (1993). Taste responsiveness in anorexia nervosa. Br J Psychiatry 162:244-246.
126. Slade PD (1982). Towards a functional analysis of anorexia nervosa and bulimia nervosa. Br J of Psychiatry 21:167-179.
127. Sobell J, Lind T, Hebrink D, Heston L, Sommer S (1997). Screening the monoamine oxidase B gene in 100 male patients with schizophrenia: a cluster of polymorphisms in African-Americans but lack of functionally significant sequence changes. Am J Med Genet 74:44-49.
128. Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC (1992). The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem Pharmacol 43:659-666.
129. Steiner H, Wilber J, Prasad C, Rogers D, Rosenkranz R (1989). Histidyl proline diketopiperazine (Cyclo [HisPro]) in eating disorders. Neuropeptides 14:185-188.
130. Stern SL, Dixon KN, Sansone RA, Lake MD, Nemzer E, Jones D (1992). Psychoactive substance use disorder in relatives of patients with anorexia nervosa. Comprehensive Psychiatry 33:207-212.
131. Ströber G, Pörtgen P, Bönisch H, Beckman H, Propping P, Nöthen M (1995). Systematic screening for mutations in the coding region of the noradrenaline transporter gene. Psychiatric Genetics S5:98.
132. Stöber M (1984). Stressful life events associated with bulimia and anorexia nervosa: empirical findings and theoretical speculations. Int J Eat Disord 3:3-16.
133. Ströber M, Morrel W, Burroughs J, Salkin B, Jacobs C (1985). A controlled family study of anorexia nervosa. J Psychiat Res 19:239-246.
134. Ströber M, Lampert C, Morrel W et al. (1990). A controlled family study of anorexia nervosa: evidence of familial aggregation and lack of shared transmission with affective disorders. Int J Eat Disord 9:239-253.
135. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier G, Georges SR et al. (1991). Cloning of the gene for a human dopainine D5 receptor with higher affinity for dopamine than Dl. Nature 350:614-619.
136. Sunday S, Halmi K (1996). Micro- and macroanalysis of patterns within a meal in anorexia and bulimia nervosa. Appetite 26:21-36.
137. Surratt C, Persico A, Yang A, Edgar S, Bird G, Hawkins A et al. (1993). A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLP. FEBS Lett 318:325-330.
138. Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T (1993). Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 42:581-584.
139. Theander S (1970). Anorexia nervosa: a psychiatric investigation of 94 female cases. Acta Psychiatrica Scand 214:(Supp), 1-94.
140. Treasure J, Tiller J (1993). The aetiology of eating disorders - its biological basis. International Rev of Psychiatry 5:23-32.
141. Uhe A, Szmukler G, Collier G, Hansky J, O'Dea K, Young G (1992). Potential regulators of feeding behaviour in anorexia nervosa. Am J Clin Nutr 55:28-32.
142. Ungerstedt U (1971). Stercotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 367(Suppl.):1-48.
143. Vandenbergh D, Persico A, Uhl G (1992a). A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Mol Brain Res 15:161-166.
144. Van Itallie T (1988). Obesity, genetics, and ponderal set point. Clin Neuropharmacol 11(Suppl 1):S1-7.
145. Van Tol HHM, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB et al. (1991). Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.
146. Vandenbergh D, Persico A, Hawkins A, Griffin C, Li X, Jabs E et al. (1992b). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.
147. Vemura H, Kobayashi H (1971). Effects of dopamine implanted in the median eminence on the estrous cycle of the rat. Endocrinol Japan 18:91-100.
148. Venisse JL (1991). Les Nouvelles Addictions. Masson, Collection Medecine et Psychiotherapie, Paris.
149. Wade T, Triggerman M, Heath A, Abraham S, Treloar S, Martin N (1996). Structure of disordered eating in a twin community sample. Int J Eat Disord 19:63-71.
150. Walters E, Kendler K (1995). Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am J Psychiatry 152:64-71.
151. Wang J, Imai Y, Eppler C, Gregor P, Spivak C, Uhl G (1993b). mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 90:10230-10234.
152. Wang Z, Crowe R, Marsh J (1993a). An SspI polymorphism for the human dopa decarboxylase (DCC) gene on chromosome 7p. Human Molecular Genetics 2:2198.
153. Wang Z, Crowe R, Marsh J (1992). An Sspl polymorphism for the human dopa decarboxylase (DCC) gene on chromosome 7p. Human Molecular Genetics 2:2198.
154. Wang J. Imai Y, Eppler C. Gregor R Spivak C, Uhl G (1993). mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 90:10230-10234.
155. Warren JT, Peacock ML, Fink JK (1992). An RsaI polymorphism in the human serotonin receptor gene (HTR1A): detection by DGGE and RFLP analysis. Human Molecular Genetics 9:778.
156. Waters BGH, Beumont PVJ, Touyz S, Kennedy M (1990). Behavioural differences between twin and non-twin female sibling pairs discordant for anorexia nervosa. Int J Eat Disord 9:265-273.
157. Weiner RI, Gorski RA, Sawyer CH (1972). Hypothalamic catecholamines and pituitary gonadotrophic function. In: Brain Endocrine Interaction. Median Eminence: Structure and Function. (Eds. M. Knigge, A.J. Phiebig), pp. 236-244. New York.
158. Weiner RI, Gangong WF (1978). Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58:905-976.
159. Weissman A, Koe BK, Tenen SS (1966). Anti-amphetamine effects following inhibition of tyrosine hydroxylase. J Pharmacol Exp Ther 151:339-352.
160. Weltzin T, Fernstrom M, Hansen D, McConaha C, Kaye W (1991). Abnormal caloric requirements for weight maintenance in patients with anorexia and bulimia nervosa. Am J Psychiatry 148:1675-1682.
161. Wise RA, Rompre PP (1989). Brain dopamine and reward. Annu Rev Psychol 40:191-225.
162. Zhou QY, Palmiter RD (1995). Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209.